To the best of our knowledge, this is the first analysis of copy number variation (CNV) of FCGR2A, FCGR2B, FCGR2C, FCGR3A and FCGR3B genes in sarcoidosis and its particular stages, which are considered as separate disease entities by some authors. This evidence concerns the gene FCGR2C and sarcoidosis.